Series C · Healthtech · Amsterdam, Netherlands · Founded 2012 · 51–200 employees
myTomorrows operates a global platform connecting patients with unmet medical needs to treatments in development through clinical trials and expanded access programs. The company has facilitated access for over 16,900 patients and 2,800 physicians across 340+ sites in over 133 countries, using AI-driven matching technology. Founded by a physician who lost his father to cancer and struggled to access experimental treatments, the platform bridges the gap between 10,000+ therapies in development and 300+ million patients worldwide without approved treatment options. The company recently raised €25 million in October 2025 led by Avego to expand its global operations.